Open tender · Germany · Pharmaceutical products
Open house Arzneimittelrabattverträge gemäß § 130a Abs. 8c SGB V Bevacizumab, ATC L01FG01
In EnglishOpen House Medicinal Product Discount Agreements under § 130a Para. 8c SGB V Bevacizumab, ATC L01FG01
AOK Bayern - Die Gesundheitskasse
AOK Bayern - Die Gesundheitskasse in Germany is inviting bids for “Open House Medicinal Product Discount Agreements under § 130a Para. 8c SGB V Bevacizumab, ATC L01FG01”. Bids close on 16 April 2027, 12:00 CEST. askTender lists every requirement to qualify and checks whether your company meets them.
The work
Non-exclusive discount agreements for Bevacizumab, ATC L01FG01, for parenteral preparations from finished medicinal products in oncology for direct medical use by patients in the region of Bavaria.
Key facts
- Procedure
- Contract notice
Before you bid, askTender
Everything else is in your askTender account
askTender has broken this tender down into 8 requirements to qualify (2 on experience, 6 certifications and registrations) and the 5 documents a bidder must file.
- What it takes to qualify: every requirement, in the tender’s own words
- Whether your company qualifies: your profile checked against each requirement, showing what you have, what’s missing and how to close the gap
- The documents to file: a checklist, with draft declarations ready to sign
- A bid partner for any requirement you can’t meet alone
- The tender documents, ready to open
- Alerts for new tenders like this one
Public data: TED – Tenders Electronic Daily. © European Union, 1998–2026. Notices reused under Commission Decision 2011/833/EU. · Sources & licences